| Patients | Healthy subjects | ||||
---|---|---|---|---|---|---|
PMT | AFCT | PT | PMT | AFCT | PT | |
Total | ||||||
 Stereovision | (0.116) | (− 0.616) |  − 0.236 |  − 0.463 |  − 0.092 | 0.139 |
 Quality of stereovision | (− 0.023) | (− 0.527) | 0.268 |  − 1.189** | 0.709* | 0.879** |
 Spatial localization/visuoconstruction | (− 0.407) | (0.246) | 0.423 |  − 0.041 |  − 0.085 |  − 0.277 |
ADL | ||||||
 Stereovision | (− 0.073) | (− 0.217) | (0.091) |  − 0.561 | 0.135 | 0.392 |
 Quality of stereovision | (− 0.084) | (− 0.263) | (0.414) |  − 1.173** | 0.770* | 1.150** |
 Spatial localization/visuoconstruction | (− 0.252) | (− 0.323) | (0.118) | 0.028 | 0.231 |  − 0.218 |
Geometric | ||||||
 Stereovision | 0.002 | (− 0.955) |  − 0.450 |  − 0.117 | (− 0.277) | (− 0.463) |
 Quality of stereovision |  − 0.401 | (− 0.862) | 0.101 |  − 0.731 | (0.193) | (− 0.108) |
 Spatial localization/visuoconstruction |  − 0.508* | (0.271) | 0.533** |  − 0.218 | (− 0.232) | (− 0.271) |